“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
Senior White House officials reported that United States service members would be among the first Americans to receive a COVID-19 vaccine after it has been licensed. Officials said the groups likely to receive the vaccine first include the most vulnerable people such as the elderly, patients with underlying health conditions, employees in essential businesses and […]
Hadassah Medical Center in partnership with the Israeli biotechnology company Kamada Ltd. in Jerusalem, Israel treated its first COVID-19 patient with what it described as a “passive vaccine.”1 Reportedly, a young female suffering from several underlying medical conditions, who had been hospitalized for several weeks and intubated, was passively vaccinated by injecting antibodies from a […]
Story Highlights Human trials for a new COVID-19 immunotherapy candidate (SAB-185) that is derived from genetically engineered cow plasma will begin in July 2020. The cows have been genetically engineered to produce human antibodies to fight off COVID-19. Plasma from the cows is expected to assist COVID-19 patients overcome the infection. SAb Biotherapeutics (SAB), a […]
Drug shortages listed by the U.S Food and Drug Administration (FDA) are exposing some of the ramifications of responses to the COVID-19 pandemic, including state lockdowns and social distancing regulations.1 Zoloft (sertraline hydrochloride), an anti-depressant manufactured by Pfizer and its generic counterparts produced by other drug makers, have been added to the FDA’s list of […]
Story Highlights A poll shows that the fear and anxiety associated with the COVID-19 pandemic has affected the mental health of almost 50 percent of Americans. Mental health experts have observed that anxiety stemming from the pandemic has come in waves beginning with anxiety about getting the infection or giving it to someone else to […]
A recent poll conducted by the Associated Press’s NORC Center for Public Affairs Research found that 20 percent of Americans anticipate that a COVID-19 vaccine will be available to the public before the end of 2020, while 61 percent expect it during 2021. Only 17 percent believe it will take longer than that to develop.1 […]
Story Highlights A recent report by Coverys Inc. found that diagnostic errors were the most common reason for medical malpractice claims from 2013 to 2017. An estimated 40,000 to 80,000 people die each year from diagnostic failures in American hospitals. Most medical diagnostic errors occur in outpatient settings and emergency departments. A recent report released by an […]
Pfizer, Inc. of New York and BioNTech SE of Mainz, Germany have announced that human clinical trials for an experimental COVID-19 vaccine they have co-developed, known as BNT162, have begun in the United States.1 As part of a global clinical development program, the first human subjects in the U.S. Phase I and Phase clinical II […]
According to the U.S. Centers for Disease Control and Prevention (CDC), the number of children diagnosed with autism in the United States continues to increase. In a report published on Mar. 27, 2020, the CDC estimated the prevalence of autism spectrum disorder (ASD) in the country is now one in 54 children—up from one in […]
Story Highlights Researchers at Texas A&M University and five other academic institutions have begun a phase 4 clinical trial re-purposing a live attenuated tuberculosis vaccine to treat COVID-19. The researchers believe that the TICE® BCG vaccine, which is licensed to prevent and treat bladder cancer, may help mitigate the severity of COVID-19. The research team […]